Aligned Genetics, Inc. (KOSDAQ:238120)

Aligned Genetics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	68,253	43,496	57,947	54,137	61,614	71,176
Market Cap Growth	48.34%	-24.94%	7.04%	-12.13%	-13.43%	46.13%
Enterprise Value	55,409	31,551	48,198	44,338	52,552	59,031
Last Close Price	4855.00	3025.00	4030.00	3765.00	4285.00	4950.00
PE Ratio	18.42	10.54	17.91	23.21	11.12	152.01
PS Ratio	3.93	2.76	3.81	3.94	5.24	8.95
PB Ratio	1.92	1.23	1.85	1.88	2.28	3.32
P/TBV Ratio	1.93	1.23	1.85	1.88	2.29	3.34
P/FCF Ratio	514.68	15.49	29.41	244.98	-	-
P/OCF Ratio	114.87	14.19	20.34	24.36	453.15	1995.34
EV/Sales Ratio	3.19	2.00	3.17	3.22	4.47	7.42
EV/EBITDA Ratio	15.90	9.40	12.15	12.67	19.34	139.69
EV/EBIT Ratio	18.93	11.35	14.44	15.56	24.12	-
EV/FCF Ratio	417.82	11.24	24.47	200.64	-	-
Debt / Equity Ratio	0.08	0.08	0.15	0.15	0.16	0.05
Debt / EBITDA Ratio	0.81	0.88	1.18	1.25	1.63	2.67
Debt / FCF Ratio	21.17	1.06	2.37	19.82	-	-
Net Debt / Equity Ratio	-0.36	-0.41	-0.33	-0.32	-0.32	-0.51
Net Debt / EBITDA Ratio	-3.72	-4.37	-2.59	-2.66	-3.20	-26.05
Net Debt / FCF Ratio	-96.86	-5.23	-5.21	-42.16	2.74	181.20
Asset Turnover	0.40	0.37	0.39	0.39	0.39	0.32
Inventory Turnover	1.11	1.15	1.20	1.64	1.98	1.62
Quick Ratio	7.14	10.86	3.37	11.38	10.98	11.18
Current Ratio	10.05	13.49	4.12	14.67	12.97	13.07
Return on Equity (ROE)	10.93%	12.36%	10.76%	8.36%	22.87%	2.21%
Return on Assets (ROA)	4.20%	4.08%	5.36%	4.99%	4.54%	-0.63%
Return on Invested Capital (ROIC)	13.20%	12.07%	15.54%	14.39%	15.16%	-2.70%
Return on Capital Employed (ROCE)	6.80%	6.60%	9.30%	8.00%	6.60%	-1.00%
Earnings Yield	5.48%	9.49%	5.58%	4.31%	8.99%	0.66%
FCF Yield	0.19%	6.46%	3.40%	0.41%	-5.15%	-0.08%
Buyback Yield / Dilution	1.33%	-	-	-	-38.26%	27.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.